Stock Performance and Market Context
On 24 Feb 2026, Trident Texofab Ltd opened with a gap down of 4.99%, immediately trading at its intraday low of Rs.87.5. This price represents the lowest level the stock has seen in the past year, a stark contrast to its 52-week high of Rs.379. The stock has underperformed its sector by 3.88% today and has been on a consecutive losing streak for 21 trading sessions, resulting in a cumulative decline of 64.53% during this period.
Further compounding the stock’s challenges, it is currently trading below all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages — signalling persistent bearish momentum. This technical weakness contrasts with the broader market, where the Sensex, despite a negative opening and a fall of 446.97 points (-0.83%) to 82,605.57, remains only 4.3% shy of its 52-week high of 86,159.02. The Sensex is trading below its 50-day moving average, yet its 50DMA remains above the 200DMA, indicating a mixed but relatively more stable market environment compared to the stock’s performance.
Financial Metrics and Fundamental Assessment
Trident Texofab’s financial fundamentals have contributed to the subdued investor sentiment. The company’s long-term return on capital employed (ROCE) stands at a modest 6.88%, reflecting limited efficiency in generating returns from its capital base. This figure is below the threshold typically favoured by market participants for sustained growth prospects.
Debt servicing capacity is another area of concern, with a high Debt to EBITDA ratio of 6.83 times, indicating significant leverage and potential strain on cash flows. Such a ratio suggests that the company’s earnings before interest, taxes, depreciation, and amortisation are insufficiently robust to comfortably cover its debt obligations, which may weigh on creditworthiness and financial flexibility.
Quarterly results for December 2025 further underline the challenges, with net sales reported at Rs.25.74 crores — the lowest quarterly sales figure recorded recently. This flat sales performance adds to the narrative of subdued business momentum in the near term.
Rising fast and still accelerating! This Small Cap from FMCG sector is riding pure momentum right now. Jump in before the rally reaches its peak!
- - Accelerating price action
- - Pure momentum play
- - Pre-peak entry opportunity
Relative Performance and Valuation Considerations
Over the past year, Trident Texofab Ltd has delivered a negative return of 50.84%, significantly lagging behind the Sensex’s positive 10.93% gain over the same period. The stock’s underperformance extends beyond the last 12 months, with returns trailing the BSE500 index across one year, three years, and the last three months, highlighting persistent challenges in maintaining competitive growth.
Despite these headwinds, the company’s valuation metrics present a nuanced picture. The enterprise value to capital employed ratio stands at an attractive 1.9, suggesting that the stock is trading at a discount relative to its capital base. Additionally, the company’s ROCE for the latest period is marginally improved at 7.4%, and profits have risen by 122.5% over the past year. This profit growth, juxtaposed with the stock’s price decline, results in a PEG ratio of 0.8, indicating that earnings growth is not fully reflected in the current share price.
Majority ownership remains with non-institutional shareholders, which may influence liquidity and trading dynamics.
Holding Trident Texofab Ltd from Garments & Apparels? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Mojo Score and Market Sentiment
MarketsMOJO assigns Trident Texofab Ltd a Mojo Score of 23.0, categorising it as a Strong Sell. This rating was upgraded from Sell to Strong Sell on 3 Feb 2026, reflecting a deterioration in the company’s overall quality and outlook. The market capitalisation grade is rated 4, indicating a relatively modest market cap within its sector.
The stock’s day change of -4.99% today and its persistent decline over the last 21 sessions underscore the prevailing cautious sentiment among market participants.
Summary of Key Metrics
To encapsulate, the stock’s 52-week low of Rs.87.5 is a culmination of sustained price erosion driven by weak long-term returns, elevated leverage, subdued sales, and underperformance relative to broader market indices. While valuation metrics suggest some degree of discounting, the overall market sentiment remains subdued as reflected in the strong sell rating and technical indicators.
Only Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Start Today
